BlackRock Fund Advisors’s ResMed RMD Stock Holding History

BlackRock Fund Advisors’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$383M	Buy	6,174,597 +39,350	+0.6%	+$2.41M	0.07%	286
2016 Q3	$398M	Buy	6,135,247 +227,199	+4%	+$15.1M	0.08%	243
2016 Q2	$374M	Buy	5,908,048 +718,599	+14%	+$42.4M	0.08%	237
2016 Q1	$300M	Sell	5,189,449 -10,085	-0.2%	-$571K	0.07%	306
2015 Q4	$279M	Buy	5,199,534 +313,054	+6%	+$17.6M	0.06%	326
2015 Q3	$249M	Sell	4,886,480 -14,739	-0.3%	-$793K	0.06%	337
2015 Q2	$276M	Buy	4,901,219 +329,361	+7%	+$20.8M	0.07%	316
2015 Q1	$328M	Buy	4,571,858 +286,424	+7%	+$18.6M	0.08%	261
2014 Q4	$240M	Sell	4,285,434 -30,174	-0.7%	-$1.58M	0.06%	364
2014 Q3	$213M	Buy	4,315,608 +162,881	+4%	+$8.3M	0.06%	358
2014 Q2	$210M	Buy	4,152,727 +136,871	+3%	+$6.78M	0.06%	373
2014 Q1	$179M	Sell	4,015,856 -105,492	-3%	-$4.74M	0.05%	426
2013 Q4	$194M	Buy	4,121,348 +204,432	+5%	+$10.3M	0.06%	380
2013 Q3	$207M	Buy	3,916,916 +156,729	+4%	+$7.6M	0.07%	302
2013 Q2	$170M	Buy	+3,760,187	New	+$178M	0.06%	355

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BlackRock Fund Advisors's RMD Position: Q4 2016 in Review

BlackRock Fund Advisors increased its ResMed (RMD) stake by 0.64% in Q4 2016, buying an estimated $2.41M and bringing the position to 6,174,597 shares worth $383M. The position accounts for 0.07% of the portfolio, ranked #286.

BlackRock Fund Advisors first reported a position in RMD in Q2 2013 and has held it in 15 quarters since. The position peaked at $398M in Q3 2016. 361 funds tracked by Wall St. Rank hold RMD as of Q4 2016.

BlackRock Fund Advisors held 6,174,597 shares of ResMed worth $383M as of Q4 2016.
BlackRock Fund Advisors bought 39,350 ResMed shares in Q4 2016, an estimated $2.41M.
ResMed made up 0.07% of BlackRock Fund Advisors's portfolio in Q4 2016, its #286 holding.
BlackRock Fund Advisors first reported a position in ResMed in Q2 2013 and has held it in 15 quarters since.
BlackRock Fund Advisors's ResMed position peaked at $398M in Q3 2016.
361 funds tracked by Wall St. Rank held ResMed as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.